Centers for Disease Control awards contract to Kephera Diagnostics for point-of-care test for Taeniasis

Centers for Disease Control awards contract to Kephera Diagnostics for point-of-care test for Taeniasis Framingham, MA – November 13, 2018.  Kephera Diagnostics has won a $150,000 Phase I SBIR contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a point-of-care test for Taeniasis, the company announced today.  The Phase I contract…